352 related articles for article (PubMed ID: 31487939)
1. The Role of
Fan M; Kim EK; Choi YJ; Tang Y; Moon SH
Int J Environ Res Public Health; 2019 Sep; 16(18):. PubMed ID: 31487939
[No Abstract] [Full Text] [Related]
2. The Effects of
Richter E; Geetha T; Burnett D; Broderick TL; Babu JR
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902074
[TBL] [Abstract][Full Text] [Related]
3. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics Reveals that Momordica charantia Attenuates Metabolic Changes in Experimental Obesity.
Gong ZG; Zhang J; Xu YJ
Phytother Res; 2017 Feb; 31(2):296-302. PubMed ID: 27878888
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects and associated mechanisms of
Wang S; Liu Q; Zeng T; Zhan J; Zhao H; Ho CT; Xiao Y; Li S
Food Funct; 2022 Nov; 13(23):11986-11998. PubMed ID: 36350105
[No Abstract] [Full Text] [Related]
6. Bitter melon: a panacea for inflammation and cancer.
Dandawate PR; Subramaniam D; Padhye SB; Anant S
Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
[TBL] [Abstract][Full Text] [Related]
7.
Bortolotti M; Mercatelli D; Polito L
Front Pharmacol; 2019; 10():486. PubMed ID: 31139079
[No Abstract] [Full Text] [Related]
8. New insights into the bioactive polysaccharides, proteins, and triterpenoids isolated from bitter melon (Momordica charantia) and their relevance for nutraceutical and food application: A review.
Bora AFM; Kouame KJE; Li X; Liu L; Pan Y
Int J Biol Macromol; 2023 Mar; 231():123173. PubMed ID: 36642359
[TBL] [Abstract][Full Text] [Related]
9. Momordica charantia and type 2 diabetes: from in vitro to human studies.
Habicht SD; Ludwig C; Yang RY; Krawinkel MB
Curr Diabetes Rev; 2014 Jan; 10(1):48-60. PubMed ID: 24295371
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo α-amylase and α-glucosidase inhibiting activities of the protein extracts from two varieties of bitter gourd (Momordica charantia L.).
Poovitha S; Parani M
BMC Complement Altern Med; 2016 Jul; 16 Suppl 1(Suppl 1):185. PubMed ID: 27454418
[TBL] [Abstract][Full Text] [Related]
11. The effects of Momordica charantia (bitter melon) supplementation in patients with primary knee osteoarthritis: A single-blinded, randomized controlled trial.
Soo May L; Sanip Z; Ahmed Shokri A; Abdul Kadir A; Md Lazin MR
Complement Ther Clin Pract; 2018 Aug; 32():181-186. PubMed ID: 30057048
[TBL] [Abstract][Full Text] [Related]
12. Bitter gourd (Momordica charantia) as a rich source of bioactive components to combat cancer naturally: Are we on the right track to fully unlock its potential as inhibitor of deregulated signaling pathways.
Farooqi AA; Khalid S; Tahir F; Sabitaliyevich UY; Yaylim I; Attar R; Xu B
Food Chem Toxicol; 2018 Sep; 119():98-105. PubMed ID: 29753870
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.
Han C; Hui Q; Wang Y
Nat Prod Res; 2008; 22(13):1112-9. PubMed ID: 18855210
[TBL] [Abstract][Full Text] [Related]
14. Comparative Analysis of Metabolite Profiling of
Fan M; Lee JI; Ryu YB; Choi YJ; Tang Y; Oh M; Moon SH; Lee B; Kim EK
Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073706
[TBL] [Abstract][Full Text] [Related]
15. Identification of chemotypes in bitter melon by metabolomics: a plant with potential benefit for management of diabetes in traditional Chinese medicine.
Zhou S; Allard PM; Wolfrum C; Ke C; Tang C; Ye Y; Wolfender JL
Metabolomics; 2019 Jul; 15(8):104. PubMed ID: 31321563
[TBL] [Abstract][Full Text] [Related]
16. Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.
Shih CC; Shlau MT; Lin CH; Wu JB
Phytother Res; 2014 Mar; 28(3):363-71. PubMed ID: 23610006
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapeutic Potential of Bitter Gourd (
Adarmanabadi SMHH; Abadi OJK; Amiri A; Tamannaeifar R; Balanian S; Rasekhjam M; Samiazar MS; Hasanpour S; Peiravi S; Alijanzadeh D; Poudineh M; Amiri H; Mazhari SA; Khademi R; Deravi N; Fathi M
J Integr Neurosci; 2024 Apr; 23(4):86. PubMed ID: 38682220
[TBL] [Abstract][Full Text] [Related]
18. Bitter gourd (Momordica charantia) possess developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos.
Khan MF; Abutaha N; Nasr FA; Alqahtani AS; Noman OM; Wadaan MAM
BMC Complement Altern Med; 2019 Jul; 19(1):184. PubMed ID: 31340810
[TBL] [Abstract][Full Text] [Related]
19.
Cortez-Navarrete M; Méndez-Del Villar M; Ramos-González EJ; Pérez-Rubio KG
J Med Food; 2021 Oct; 24(10):1017-1027. PubMed ID: 33733863
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of poultry associated bacterial pathogens to Momordica charantia fruits and evaluation of in vitro biological properties.
Lydia D E; Gupta C; Khusro A; Salem AZM
Microb Pathog; 2019 Jul; 132():222-229. PubMed ID: 31059755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
